Trump anounces deal with Pfizer to lower drug costs

Published



President Donald Trump and the pharmaceutical giant Pfizer announced an agreement Tuesday to lower medication costs for Medicaid patients, advancing Trump’s “Most Favored Nation” pricing effort to reduce the cost of American prescription drugs.

Trump announced alongside Pfizer CEO Albert Bourla in the Oval Office the pharmaceutical giant would implement a series of new policies to reduce drug prices for American patients as early as the beginning of next year.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.